IceCure's Advanced Multiprobe Cryoablation Technology Receives Patent Approval in Japan
November 25, 2024 - 22:01
IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
MORE NEWS
June 27, 2026 - 21:55
World's first 100% electric hydrofoil pilot boat hits the waterArtemis Technologies has unveiled its newest electric hydrofoil vessel, the EF-12, calling it the world`s first completely electric and zero-emissions pilot boat. Designed specifically for...
June 27, 2026 - 00:43
UCF abruptly shuts down some campus libraries and technology resourcesThe University of Central Florida has suddenly shut down several campus libraries and technology resource centers, leaving students and staff scrambling for alternatives. The closures took effect...
June 26, 2026 - 00:10
Partnership with Oxford Nanopore Technologies will support development of RNA liquid biopsy for cancer early detectionA new partnership between a diagnostics company and Oxford Nanopore Technologies is set to push forward the development of a blood test that can spot cancer at its earliest stages. The...
June 25, 2026 - 01:09
Micron Technology, Inc. Reports Record Results for the Third Quarter of Fiscal 2026BOISE, Idaho -- Micron Technology, Inc. reported financial results for the third quarter of fiscal 2026, posting record revenue of $41.46 billion. The figure marks a sharp increase from $23.86...